Clinical Trials
3 trialsNCT05027425 2026-05-06
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Terminated
NCT04499833 2022-06-06
HepatoPredict
Centro Hospitalar de Lisboa Central
Phase NA Recruiting
NCT01387503 2021-10-11
Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Completed